Literature DB >> 28473071

ACR Appropriateness Criteria® Hematospermia.

Keyanoosh Hosseinzadeh1, Aytekin Oto2, Brian C Allen3, Fergus V Coakley4, Barak Friedman5, Pat F Fulgham6, Matthew S Hartman7, Matthew T Heller8, Christopher Porter9, V Anik Sahni10, Gary S Sudakoff11, Sadhna Verma12, Carolyn L Wang13, Don C Yoo14, Erick M Remer15, Steven C Eberhardt16.   

Abstract

Most men with hematospermia or hemospermia (HS) are young (<40 years of age), presenting with transient or episodic HS without other signs or symptoms of disease. The condition is self-limiting in most cases and idiopathic in nature. When a cause can be identified, infections of the urogenital tract are the most common. Imaging does not play a role in this patient population. In older men (>40 years of age), clinical screening for prostate cancer is advised. Furthermore, when HS is persistent or has symptoms, causes include obstruction or stricture at the level of the verumontanum, calcifications or calculi in the prostate, ejaculatory ducts or seminal vesicles, and cysts arising within these structures. Noninvasive imaging, predominantly transrectal ultrasound (TRUS) and MRI, can be used in men of any age with persistent or refractory HS, or other associated symptoms or signs. TRUS is considered as the first-line imaging with MRI used when TRUS is inconclusive or negative. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer-reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2017 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Appropriate Use Criteria; Appropriateness Criteria; MRI; TRUS; hematospermia; hemospermia; ultrasound

Mesh:

Year:  2017        PMID: 28473071     DOI: 10.1016/j.jacr.2017.02.023

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  3 in total

1.  Transrectal ultrasound-guided seminal vesicle catheterization with continuous antibiotic infusion for the treatment of refractory hematospermia.

Authors:  Ren Wang; Lei Chen; Xiaojun Bai; Tingting Li; Dan Wu; Jinjin Chen
Journal:  Exp Ther Med       Date:  2020-11-11       Impact factor: 2.447

2.  Transurethral seminal vesiculoscopy for intractable hematospermia: experience from 144 patients.

Authors:  Wei-Kang Chen; Dong-Dong Yu; Zhi-Xia Chen; Peng-Fei Li; Jian Cai; Yu-Peng Liu; Zhi-Gang Wu
Journal:  BMC Urol       Date:  2021-03-27       Impact factor: 2.264

3.  Successful treatment of seminal vesicle calculi and prostatic utricle calculi by transurethral seminal vesiculoscopy.

Authors:  Liming Song; Hu Han; Hongen Lei; Yun Cui; Sujuan Feng; Xiaodong Zhang; Long Tian
Journal:  Andrologia       Date:  2020-08-26       Impact factor: 2.775

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.